Butterfly Network (BFLY) Capital Expenditures (QoQ) (2020 - 2026)
Butterfly Network (BFLY) Capital Expenditures (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Butterfly Network | 1.76 Bn | 1.62 Bn | 18.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150.83% |
| Dec 31, 2025 | -283.96% |
| Sep 30, 2025 | 13.39% |
| Jun 30, 2025 | 153.82% |
| Mar 31, 2025 | -13.48% |
| Dec 31, 2024 | -1.45% |
| Sep 30, 2024 | -43.60% |
| Jun 30, 2024 | -35.50% |
| Mar 31, 2024 | -54.70% |
| Dec 31, 2023 | 139.69% |
| Sep 30, 2023 | 18.96% |
| Jun 30, 2023 | -34.35% |
| Mar 31, 2023 | 111.49% |
| Dec 31, 2022 | -353.78% |
| Sep 30, 2022 | -34.93% |
| Jun 30, 2022 | 56.95% |
| Mar 31, 2022 | 11.23% |
| Dec 31, 2021 | 102.85% |
| Sep 30, 2021 | 269.81% |
| Jun 30, 2021 | -58.11% |